Immune-toxicity model and efficacy biomarkers enable precise NSCLC immunotherapy stratification
A new analysis of the phase 3 ORIENT-11 trial suggests that the future of lung-cancer immunotherapy may depend not only ...
A new analysis of the phase 3 ORIENT-11 trial suggests that the future of lung-cancer immunotherapy may depend not only ...
In recent years, the challenge of diagnosing serious bacterial infections (SBIs) in febrile infants has posed a formidable obstacle for ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine